In this protocol, primary embryonic mesenchymal cells are used as feeders for the expansion of definitive endoderm and endocrine progenitor cells. Mesenchymal progenitor cells can promote up to 6-million-fold expansion of embryonic stem cell-derived definitive endoderm cells. These expanded cells are further differentiated into pancreatic progenitor cells.